Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications F Zhang, RI Lau, Q Liu, Q Su, FKL Chan, SC Ng Nature Reviews Gastroenterology & Hepatology 20 (5), 323-337, 2023 | 101 | 2023 |
Faecal microbiome-based machine learning for multi-class disease diagnosis Q Su, Q Liu, RI Lau, J Zhang, Z Xu, YK Yeoh, TWH Leung, W Tang, ... Nature Communications 13 (1), 6818, 2022 | 48 | 2022 |
Post-acute COVID-19 syndrome and gut dysbiosis linger beyond 1 year after SARS-CoV-2 clearance Q Su, RI Lau, Q Liu, FKL Chan, SC Ng Gut 72 (6), 1230-1232, 2023 | 28 | 2023 |
A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial RI Lau, Q Su, ISF Lau, JYL Ching, MCS Wong, LHS Lau, HM Tun, ... The Lancet Infectious Diseases 24 (3), 256-265, 2024 | 8 | 2024 |
The gut microbiome associates with phenotypic manifestations of post-acute COVID-19 syndrome Q Su, RI Lau, Q Liu, MKT Li, JWY Mak, W Lu, ISF Lau, LHS Lau, ... Cell Host & Microbe 32 (5), 651-660. e4, 2024 | 1 | 2024 |
378 FAECAL MICROBIOTA TRANSPLANTATION FOR POST-ACUTE COVID-19 SYNDROME: AN OPEN-LABEL PILOT TRIAL (FMT-PACS STUDY) RI Lau, Q Su, JY Ching, RN Lui, TT Chan, MT Wong, LHS Lau, YK Wing, ... Gastroenterology 166 (5), S-82-S-83, 2024 | | 2024 |
913a MODULATION OF GUT MICROBIOME ALLEVIATES POST-ACUTE COVID-19 SYNDROME: A RANDOMISED, TRIPLE-BLIND, PLACEBO-CONTROLLED TRIAL (RECOVERY STUDY) RI Lau, JY Ching, MC Wong, LHS Lau, SFI Lau, YTR Leung, WY Chin, ... Gastroenterology 164 (6), S-1571, 2023 | | 2023 |
Sa1060 GASTROINTESTINAL INVOLVEMENT IN POST-ACUTE COVID-19 SYNDROME: RESULTS FROM A POPULATION-BASED STUDY OF 8,156 SUBJECTS RI Lau, SFI Lau, JY Ching, W Tang, KCJ Chiu, PK Cheong, MHA Pak, ... Gastroenterology 164 (6), S-278, 2023 | | 2023 |
Role of gut microbiota in acute COVID-19 and post-acute COVID-19 syndrome Q Liu, Q Su, RI Lau, F Zhang, FKL Chan, SC Ng Microbiota in Health and Disease, e780, 2022 | | 2022 |